David L. Castaldi serves as Executive at NABI BIOPHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, David L. Castaldi has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 19, 2007 involved selling 14,800 shares valued at $0.
David L. Castaldi currently holds 13,550 shares of NABI BIOPHARMACEUTICALS (NABI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David L. Castaldi has been a net neutral trader of NABI stock. They have purchased $0 and sold $0 worth of shares.
David L. Castaldi's most recent insider trade was on Jan 19, 2007, when they sold 14,800 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 19, 2007 | EMBX | $0 | Disposition | 2,500 | $N/A | Discretionary |
| Jan 19, 2007 | EMBX | $0 | Disposition | 3,500 | $N/A | Discretionary |
| Jul 20, 2006 | EMBX | $0 | Award | 1,250 | $N/A | Discretionary |
| May 12, 2006 | NABI | $20.0K | Award | 3,174 | $6.30 | Discretionary |